Through the partnership, Kleer’s clients will have access to Overjet’s AI technology, according to a July 12 news release.
Overjet’s AI analyzes X-rays and radiographs to detect decay and bone loss in real time. The company’s AI technology recently earned its fourth FDA clearance.
Kleer’s cloud-based software and membership platform allows practices to offer membership plans to patients and employers, improving access to care and treatment acceptance.
